ClariVest Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.39K Hold
21
﹤0.01% 507
2024
Q2
$2.39K Sell
21
-16
-43% -$2.02K ﹤0.01% 507
2024
Q1
$5.13K Buy
37
+16
+76% +$2.01K ﹤0.01% 462
2023
Q4
$2.61K Hold
21
﹤0.01% 515
2023
Q3
$1K Buy
21
+5
+31% +$564 ﹤0.01% 612
2023
Q2
$2K Buy
16
+3
+23% +$363 ﹤0.01% 512
2023
Q1
$2K Hold
13
﹤0.01% 558
2022
Q4
$1K Buy
+13
New +$1.43K ﹤0.01% 613
2021
Q1
Sell
-4,400
Closed -$407K 753
2020
Q4
$407K Sell
4,400
-1,200
-21% -$107K 0.01% 421
2020
Q3
$577K Sell
5,600
-400
-7% -$41.8K 0.02% 343
2020
Q2
$608K Sell
6,000
-50,000
-89% -$4.47M 0.02% 378
2020
Q1
$3.77M Buy
56,000
+23,200
+71% +$1.44M 0.11% 120
2019
Q4
$1.79M Buy
+32,800
New +$1.56M 0.04% 258

Other funds holding DXCM

ClariVest Asset Management's DXCM Position: Q3 2024 in Review

ClariVest Asset Management held its DexCom (DXCM) position steady in Q3 2024 at 21 shares worth $2.39K. The position accounts for ﹤0.01% of the portfolio, ranked #507.

ClariVest Asset Management first reported a position in DXCM in Q4 2019 and has held it in 13 quarters since. The position peaked at $3.77M in Q1 2020. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • ClariVest Asset Management held 21 shares of DexCom worth $2.39K as of Q3 2024.
  • ClariVest Asset Management left its DexCom share count unchanged in Q3 2024.
  • DexCom made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #507 holding.
  • ClariVest Asset Management first reported a position in DexCom in Q4 2019 and has held it in 13 quarters since.
  • ClariVest Asset Management's DexCom position peaked at $3.77M in Q1 2020.
  • 890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.